Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

30 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Humoral and cell-mediated response against SARS-CoV-2 variants elicited by mRNA vaccine BNT162b2 in healthcare workers: a longitudinal observational study.
Cassaniti I, Bergami F, Percivalle E, Gabanti E, Sammartino JC, Ferrari A, Adzasehoun KMG, Zavaglio F, Zelini P, Comolli G, Sarasini A, Piralla A, Ricciardi A, Zuccaro V, Maggi F, Novazzi F, Simonelli L, Varani L, Lilleri D, Baldanti F. Cassaniti I, et al. Among authors: zavaglio f. Clin Microbiol Infect. 2022 Feb;28(2):301.e1-301.e8. doi: 10.1016/j.cmi.2021.09.016. Epub 2021 Sep 25. Clin Microbiol Infect. 2022. PMID: 34582981 Free PMC article.
Human cytomegalovirus (HCMV)-specific T cell but not neutralizing or IgG binding antibody responses to glycoprotein complexes gB, gHgLgO, and pUL128L correlate with protection against high HCMV viral load reactivation in solid-organ transplant recipients.
Lilleri D, Zelini P, Fornara C, Zavaglio F, Rampino T, Perez L, Gabanti E, Gerna G. Lilleri D, et al. Among authors: zavaglio f. J Med Virol. 2018 Oct;90(10):1620-1628. doi: 10.1002/jmv.25225. Epub 2018 Jul 10. J Med Virol. 2018. PMID: 29797330
A snapshot of the immunogenicity, efficacy and safety of a full course of BNT162b2 anti-SARS-CoV-2 vaccine in cancer patients treated with PD-1/PD-L1 inhibitors: a longitudinal cohort study.
Lasagna A, Agustoni F, Percivalle E, Borgetto S, Paulet A, Comolli G, Sarasini A, Bergami F, Sammartino JC, Ferrari A, Zavaglio F, Arena F, Lilleri D, Secondino S, Falzoni M, Schiavo R, Klersy C, Lo Cascio G, Cavanna L, Baldanti F, Pedrazzoli P, Cassaniti I. Lasagna A, et al. Among authors: zavaglio f. ESMO Open. 2021 Oct;6(5):100272. doi: 10.1016/j.esmoop.2021.100272. Epub 2021 Sep 1. ESMO Open. 2021. PMID: 34543863 Free PMC article.
Robust and Persistent B- and T-Cell Responses after COVID-19 in Immunocompetent and Solid Organ Transplant Recipient Patients.
Zavaglio F, Frangipane V, Morosini M, Gabanti E, Zelini P, Sammartino JC, Ferrari A, Gregorini M, Rampino T, Asti A, Seminari E, Di Matteo A, Cattadori B, Pellegrini C, Tonello S, Mallela VR, Minisini R, Rizzi M, Sainaghi PP, Meloni F, Lilleri D, Baldanti F. Zavaglio F, et al. Viruses. 2021 Nov 11;13(11):2261. doi: 10.3390/v13112261. Viruses. 2021. PMID: 34835067 Free PMC article.
Immune Response to BNT162b2 in Solid Organ Transplant Recipients: Negative Impact of Mycophenolate and High Responsiveness of SARS-CoV-2 Recovered Subjects against Delta Variant.
Cassaniti I, Bergami F, Arena F, Sammartino JC, Ferrari A, Zavaglio F, Curti I, Percivalle E, Meloni F, Pandolfi L, Pellegrini C, Turco A, Seminari E, Pattonieri EF, Gregorini M, Rampino T, Sarasini A, Lilleri D, Baldanti F. Cassaniti I, et al. Among authors: zavaglio f. Microorganisms. 2021 Dec 18;9(12):2622. doi: 10.3390/microorganisms9122622. Microorganisms. 2021. PMID: 34946223 Free PMC article.
Analysis of the humoral and cellular immune response after a full course of BNT162b2 anti-SARS-CoV-2 vaccine in cancer patients treated with PD-1/PD-L1 inhibitors with or without chemotherapy: an update after 6 months of follow-up.
Lasagna A, Lilleri D, Agustoni F, Percivalle E, Borgetto S, Alessio N, Comolli G, Sarasini A, Bergami F, Sammartino JC, Ferrari A, Zavaglio F, Arena F, Secondino S, Falzoni M, Schiavo R, Lo Cascio G, Cavanna L, Baldanti F, Pedrazzoli P, Cassaniti I. Lasagna A, et al. Among authors: zavaglio f. ESMO Open. 2022 Feb;7(1):100359. doi: 10.1016/j.esmoop.2021.100359. Epub 2021 Dec 11. ESMO Open. 2022. PMID: 34973510 Free PMC article.
Human Cytomegalovirus-Specific T-Cell Reconstitution and Late-Onset Cytomegalovirus Infection in Hematopoietic Stem Cell Transplantation Recipients following Letermovir Prophylaxis.
Gabanti E, Borsani O, Colombo AA, Zavaglio F, Binaschi L, Caldera D, Sciarra R, Cassinelli G, Alessandrino EP, Bernasconi P, Ferretti VV, Lilleri D, Baldanti F. Gabanti E, et al. Among authors: zavaglio f. Transplant Cell Ther. 2022 Apr;28(4):211.e1-211.e9. doi: 10.1016/j.jtct.2022.01.008. Epub 2022 Jan 15. Transplant Cell Ther. 2022. PMID: 35042012 Free article.
30 results